Ulcers

·MeSH: Ulcer

23 drugs in development·19 companies·1 clinical trial

Drug Pipeline by Phase

Approved(16)

Drug	Company
accelerex impregnated sterile wound dressing	REGENEREX PHARMA, INC. (RGPX)
accelerex sterile wound	REGENEREX PHARMA, INC. (RGPX)
altrazeal	ULURU INC. (ULU)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
diclofenac	Miromatrix Medical Inc. (MIRO)
EPIFIX	MiMedx Group Inc (MDXG)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
grafix	OSIRIS THERAPEUTICS, INC. (OSIR)
HELIOGEN Fibrillar Collagen Matrix	MiMedx Group Inc (MDXG)
Luxamend	Journey Medical Corp (DERM)
ultramist	SANUWAVE Health Inc. (SNWV)
xcellderma otc	REGENEREX PHARMA, INC. (RGPX)

Phase 2(1)

Drug	Company
cenplacel-l	Celularity Inc. (CELU)

Phase 1(1)

Drug	Company
Esomeprazole	Keros Therapeutics, Inc. (KROS)

Preclinical(3)

Drug	Company
ipoxyn	NANOMIX CORP (BTHI)
lyoccp	NULIFE SCIENCES, INC. (NULF)
vybrin	Vicapsys Life Sciences, Inc. (VICP)

Unknown(2)

Drug	Company
Celularity Placental Matrix (CPM)	Celularity Inc. (CELU)
Esomeprazole	Crinetics Pharmaceuticals, Inc. (CRNX)

BioSniper tracks 23 drugs in development for Ulcers across 19 companies.

There are 1 clinical trial targeting Ulcers tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.